Pharmaceutical - France

Filter

Current filters:

France

Popular Filters

1 to 25 of 30 results

EUCOPE slams French plans to cut spending through off-label drugs

EUCOPE slams French plans to cut spending through off-label drugs

12-07-2014

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) says it is very concerned about legislative…

AvastinEuropeFranceLegalOphthalmicsPharmaceuticalRegulationRoche

Sanofi Pasteur releases pivotal Ph III results from dengue vaccine study

Sanofi Pasteur releases pivotal Ph III results from dengue vaccine study

11-07-2014

Sanofi Pasteur, the vaccines division of French drug major Sanofi, has announced detailed results of…

FrancePharmaceuticalResearchSanofi PasteurVaccines

France adopts draft law on off-label use of drugs

France adopts draft law on off-label use of drugs

09-07-2014

The French National Assembly yesterday voted on the draft law proposal, which would potentially allow…

AvastinDraft law proposalEuropeFranceLegalOphthalmicsPharmaceuticalRegulationRoche

French pharma trade group teams up with police to counter fake medicine

French pharma trade group teams up with police to counter fake medicine

08-07-2014

The French pharmaceutical trade group Les Entreprises du Medicament (Leem) has joined forces with a police…

FranceLegalPharmaceutical

Smarter research spending would boost French innovation, says OECD

27-06-2014

Encouraging private-sector innovation, making public research institutions more accountable and channelling…

FinancialFrancePharmaceuticalPoliticsResearch

Stallergenes publishes review of grass pollen tablet confirming efficacy

Stallergenes publishes review of grass pollen tablet confirming efficacy

24-06-2014

French allergen specialist Stallergenes has released comprehensive new data on the 5-grass pollen immunotherapy…

FrancePharmaceuticalResearchRespiratory and PulmonaryStallergenes

Eisai’s Fycompa debuts in France following reimbursement agreement

21-05-2014

Japanese pharma company Eisai has launched its Fycompa (perampanel), the first in an entirely new class…

EisaiFranceFycompaMarkets & MarketingNeurologicalPharmaceuticalPricing

AAN 2014: Genzyme’s Lemtrada slows brain atrophy in MS patients

AAN 2014: Genzyme’s Lemtrada slows brain atrophy in MS patients

01-05-2014

French drug major Sanofi and its subsidiary Genzyme presented positive new data from the Lemtrada (alemtuzumab)…

Autoimmune diseasesFranceGenzymeHealthLemtradaMajorMRIMultiple sclerosisNeurologicalPharmaceuticalResearch

Ipsen sales up in first quarter, boosted by specialty care

Ipsen sales up in first quarter, boosted by specialty care

30-04-2014

French drugmaker Ipsen has reported sales of 305.9 million euros ($423 million) for the first quarter…

Business FinanceBusiness FinanceDecapeptylDysportEURFinancialFranceIpsenPfizerPharmaceuticalSomatulineTriptorelin

Sanofi appoints Dr Anne Beal as chief patient officer

Sanofi appoints Dr Anne Beal as chief patient officer

31-03-2014

French drug major Sanofi has announced the appointment of Anne Beal to the newly created position of…

BiotechnologyBoardroomFrancePharmaceuticalSanofiUSA

Trophos announces top-line results in trial of olesoxime in spinal muscular atrophy

10-03-2014

French privately-owned biopharmaceutical firm Trophos has released top-line results from a pivotal clinical…

FranceNeurologicalolesoximePharmaceuticalResearchTrophos

UK’s Redx Pharma signs oncology collaboration with Pierre Fabre

UK’s Redx Pharma signs oncology collaboration with Pierre Fabre

07-03-2014

UK-based drug discovery company Redx Pharma and privately-owned French health care company Pierre Fabre…

FranceOncologyPharmaceuticalPierre FabreRedx PharmaResearchUK

Genticel appoints Dr Sophie Olivier as chief medical officer

04-03-2014

French biopharmaceutical company Genticel has recruited Sophie Olivier as chief medical officer to lead…

BiotechnologyBoardroomFrancePharmaceutical

Skyepharma launches Flutiform in France for asthma

10-02-2014

UK drug delivery specialist Skyepharma has received regulatory approval and agreement on pricing reimbursement…

FlutiformFranceMarkets & MarketingMundipharmaPharmaceuticalRespiratory and PulmonarySkyepharma

Ipsen posts top results for Phase III study of Decapeptyl in prostate cancer

Ipsen posts top results for Phase III study of Decapeptyl in prostate cancer

07-02-2014

French drugmaker Ipsen has announced that the Phase III clinical trial evaluating Decapeptyl (triptorelin…

DecapeptylFranceIpsenOncologyPharmaceuticalResearch

Sanofi renews alliance with Regulus and ups investment by $10 million

Sanofi renews alliance with Regulus and ups investment by $10 million

05-02-2014

US pharma company Regulus Therapeutics has renewed its strategic alliance with French drug major Sanofi…

FinancialFranceOncologyPharmaceuticalRare diseasesRegulus TherapeuticsResearchSanofiUSA

Ipsen’s Dysport next generation shows safety and efficacy in Phase III

Ipsen’s Dysport next generation shows safety and efficacy in Phase III

05-02-2014

French drugmaker Ipsen today announced the results of the international Phase III clinical trial of Dysport…

DysportFranceGeneticsIpsenPharmaceuticalResearch

Curie-Cancer and Servier renew partnership into ‘triple negative’ breast cancers

Curie-Cancer and Servier renew partnership into ‘triple negative’ breast cancers

28-01-2014

French privately-held drugmaker Servier has renewed its partnership with Curie-Cancer to identify therapeutic…

FranceOncologyPharmaceuticalResearchServier

Santhera's Raxone granted temporary use in France

21-01-2014

Switzerland-based Santhera Pharmaceuticals (SIX: SANN) announced today that the French National Agency…

FranceNeurologicalPharmaceuticalRaxoneRegulationSanthera Pharmaceuticals

1 to 25 of 30 results

Back to top